GLP-1 medications like semaglutide and tirzepatide can be helpful for many people, but theyre not suitable for everyone
Berti, A., Rose, W., Nizet, V
Similar content being viewed by others Introduction Weight loss can arise in a variety of clinical contexts, including chronic diseases such as anorexia nervosa and inflammatory bowel disease, as well as from active medical interventions like bariatric surgery and pharmacotherapy
10.2903/j.efsa.2015.4150 20 EggerM.Davey SmithG.SchneiderM.MinderC
Mimicry experiments of glucagon signalling have fuelled the development of several pharmacological compounds including glucagon receptor (GCGR) antagonists, GCGR agonists and, more recently, dual and triple receptor agonists combining glucagon and incretin hormone receptor agonism